CDK12 Antibody

Code CSB-PA882147LA01HU
Size US$166
Order now
  • Western Blot
    Positive WB detected in: Hela whole cell lysate, K562 whole cell lysate
    All lanes: CDK12 antibody at 2µg/ml
    Goat polyclonal to rabbit IgG at 1/50000 dilution
    Predicted band size: 165, 164, 142 kDa
    Observed band size: 165 kDa

The Latest Promotion Free Antibody trial simple
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Full Product Name
Rabbit anti-Homo sapiens (Human) CDK12 Polyclonal antibody
Uniprot No.
Target Names
Alternative Names
arginine/serine-rich antibody; Cdc2 related kinase arginine/serine rich antibody; CDC2 related protein kinase 7 antibody; Cdc2-related kinase antibody; CDC2-related protein kinase 7 antibody; Cdk12 antibody; CDK12_HUMAN antibody; Cell division cycle 2 related protein kinase 7 antibody; Cell division cycle 2-related protein kinase 7 antibody; Cell division protein kinase 12 antibody; CRK7 antibody; CRKR antibody; CrkRS antibody; Cyclin-dependent kinase 12 antibody; EC antibody; hCDK12 antibody; kiaa0904 antibody; Pksc antibody
Raised in
Species Reactivity
Recombinant Human Cyclin-dependent kinase 12 protein (1309-1490AA)
Immunogen Species
Homo sapiens (Human)

The CDK12 Antibody (Product code: CSB-PA882147LA01HU) is Non-conjugated. For CDK12 Antibody with conjugates, please check the following table.

Available Conjugates
Conjugate Product Code Product Name Application
HRP CSB-PA882147LB01HU CDK12 Antibody, HRP conjugated ELISA
FITC CSB-PA882147LC01HU CDK12 Antibody, FITC conjugated
Biotin CSB-PA882147LD01HU CDK12 Antibody, Biotin conjugated ELISA
Purification Method
>95%, Protein G purified
It differs from different batches. Please contact us to confirm it.
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Tested Applications
Recommended Dilution
Application Recommended Dilution
WB 1:500-1:5000
Troubleshooting and FAQs
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

The CDK12 antibody is a polyclonal IgG antibody developed in a rabbit. The immunogen is the recombinant human CDK12 protein (1309-1490aa). The purity of this CDK12 antibody exceeds 95% using protein G purification. This CDK12 antibody is specifically reactive with human species. The reactivity of this OCLN antibody with the CDK12 protein has been confirmed by ELISA and WB assays.

CDK12 is a kinase enzyme that regulates the expression of genes involved in various cellular processes, including transcription, DNA damage response and repair, and cell cycle regulation. Mutations in the CDK12 gene have been identified in a subset of tumors, including ovarian, breast, and prostate cancers.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Cyclin-dependent kinase that phosphorylates the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A), thereby acting as a key regulator of transcription elongation. Regulates the expression of genes involved in DNA repair and is required for the maintenance of genomic stability. Preferentially phosphorylates 'Ser-5' in CTD repeats that are already phosphorylated at 'Ser-7', but can also phosphorylate 'Ser-2'. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogen inhibitors.
Gene References into Functions
  1. Cyclin K expression positively correlates with cell proliferation; knockdown of cyclin K or its cognate kinase CDK12 prevents the assembly of prereplicative complex in the G1 cell cycle phase. PMID: 29760377
  2. CDK12 regulates prereplicative complex assembly to promote mammalian cell proliferation. PMID: 29760377
  3. CDK12 gene amplification can contribute to the pathogenesis of breast cancer. PMID: 28334900
  4. BRCA1 downregulation combined with CHK1 inhibition induced excessive amounts of DNA damage, resulting in an inability to complete the S-phase. Therefore, we suggest CHK1 inhibition as a strategy for targeting BRCA1- or CDK12-deficient tumors. PMID: 29025359
  5. In Ovarian Cancer patients CDK12 loss is consistently associated with a particular genomic instability pattern characterized by hundreds of tandem duplications PMID: 26787835
  6. Structures of CDK12/CycK complexes solved in the presence of AMP-PNP. PMID: 26597175
  7. Data show that most mutations prevent formation of the cyclin-dependent kinase 12 (Cdk12)/cyclin K (CycK) complex, rendering the kinase inactive. PMID: 25712099
  8. CDK12 affects RNA processing events in two distinct ways: Indirectly through generating factor-binding phospho-epitopes on the CTD of elongating RNAPII and directly through binding to specific factors PMID: 25429106
  9. CDK12 and CDK13 losses in HCT116 cells preferentially affect expression of DNA damage response. PMID: 25561469
  10. CDK12 plays an important role in cotranscriptional processing of c-FOS transcripts PMID: 25384976
  11. CDK12 has properties that should confirm interest in its use as a biomarker. PMID: 24240700
  12. many CDK12 mutations are an unrecognized cause of HR defects in ovarian cancers PMID: 24554720
  13. CDK12 interacts with cyclin K and is required to maintain embryonnic stem cell self-renewal. PMID: 22547058
  14. Cyclin K1 is the primary cyclin partner for CDK12/CrkRS and it is required for activation of CDK12/CrkRS to phosphorylate the C-terminal domain of RNA Pol II. PMID: 22988298
  15. through regulation of expression of DNA damage response genes, CycK/Cdk12 protects cells from genomic instability PMID: 22012619
  16. Data show that siRNA knockdown of hCDK12 in HeLa cells results in alterations in the CTD phosphorylation state. PMID: 20952539
  17. CRK7 modifies MAP kinases regulation and resistance to estrogen signaling inhibitors in breast cancers. PMID: 19651820

Show More

Hide All

Involvement in disease
Chromosomal aberrations involving CDK12 may be a cause gastric cancer. Deletions within 17q12 region producing fusion transcripts with ERBB2, leading to CDK12-ERBB2 fusion leading to trunctated CDK12 protein not in-frame with ERBB2.
Subcellular Location
Nucleus. Nucleus speckle. Note=Colocalized with nuclear speckles throughout interphase.
Protein Families
Protein kinase superfamily, CMGC Ser/Thr protein kinase family, CDC2/CDKX subfamily
Tissue Specificity
Ubiquitously expressed.
Database Links

HGNC: 24224

OMIM: 615514

KEGG: hsa:51755

STRING: 9606.ENSP00000398880

UniGene: Hs.345028

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
7505 Fannin St., Ste 610, Room 322 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details


II. Contact details


III. Ship To


IV. Bill To